Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquila Healthcare was a healthcare products and medical device company launched in early 2020 by Aquila Group Holdings to supply protective equipment, diagnostic tools, and disposable medical products for healthcare professionals. The company marketed products under the AQUILAVIE brand, including medical-grade masks, gloves, laboratory equipment, rapid antigen tests, and other single-use products for medical, dental, veterinary, and consumer settings. Its business appears to have focused on product design, sourcing, quality control, packaging, distribution, and international supply-chain management rather than therapeutic drug development. Public-facing materials describe a Hong Kong world headquarters and manufacturing/sourcing operations in Shenzhen, China, with emphasis on global supply to hospitals, laboratories, and government or institutional buyers. However, the UK legal entity AQUILA HEALTHCARE LTD was dissolved on May 18, 2021, so the exact current corporate status of the broader brand/operating organization is somewhat mixed across sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aquila Healthcare.